
Breakthroughs in Rapid Diagnostics and Susceptibility Testing for CRE and MBL Infections
Tuesday, April 28th 2026 - 2:45 PM (IST)
23 days to go
415 doctors attending
Tuesday, April 28th 2026 - 2:45 PM (IST)
About this session
Dr. Balaji Veeraraghavan leads this forward-looking session on the transformative role of rapid diagnostics in managing carbapenem-resistant Enterobacterales (CRE) and metallo-beta-lactamase (MBL) infections. The discussion delves into cutting-edge diagnostic technologies and advanced susceptibility testing approaches that enable early detection, guide precision therapy, and improve clinical outcomes in high-risk ICU patients.
Faculty
Key details
Registration
Free
Duration
30 min
Replay
Yes
Certificate
No
Language
English
Explore other sessions

